UK approves Moderna COVID-19 shot for 12- to 17-year-olds

Download

Britain's health regulator has approved Moderna Inc's COVID-19 vaccine for use in children aged 12 to 17 years, it said on Tuesday.
The approval comes more than two months after Pfizer and German partner BioNTech's COVID-19 vaccine got a regulatory nod for use in children aged 12 to 15.

Source(s): Reuters

Open in CGTN APP for better experience

Search Trends